Point72 Asset Management
ARRY

Point72 Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Point72 Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-500,000
Closed -$12.2M – 1660
2019
Q1 		$12.2M Hold
500,000
– – 0.06% 358
2018
Q4 		$7.13M Buy
+500,000
New +$7.58M 0.03% 476
2018
Q1 		– Sell
-1,020,900
Closed -$13.1M – 1221
2017
Q4 		$13.1M Buy
+1,020,900
New +$11.6M 0.06% 393
2017
Q2 		– Sell
-500,000
Closed -$4.47M – 1087
2017
Q1 		$4.47M Buy
+500,000
New +$5.32M 0.02% 556

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management's ARRY Position: Q2 2019 in Review

Point72 Asset Management sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 2,503,248 shares — an estimated $61M sold.

Point72 Asset Management first reported a position in ARRY in Q3 2014 and held it in 11 quarters. The position peaked at $111M in Q3 2017. 319 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Point72 Asset Management reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • Point72 Asset Management sold 2,503,248 Array Biopharma Inc shares in Q2 2019, an estimated $61M.
  • Point72 Asset Management first reported a position in Array Biopharma Inc in Q3 2014 and held it in 11 quarters.
  • Point72 Asset Management's Array Biopharma Inc position peaked at $111M in Q3 2017.
  • 319 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Point72 Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.